23 May 2013
Keywords: isis, drops, genital, wart, treatment, antisense, specialist
Article | 15 January 1996
Antisense specialist Isis Pharmaceuticals has decided to withdraw its human papilloma virus inhibitor ISIS 2105 from development, after lackluster results were ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.